{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T19:54:06Z","timestamp":1771617246123,"version":"3.50.1"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T00:00:00Z","timestamp":1583280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Malar J"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Ethiopia has set a goal for malaria elimination by 2030. Low parasite density infections may go undetected by conventional diagnostic methods (microscopy and rapid diagnostic tests) and their contribution to malaria transmission varies by transmission settings. This study quantified the burden of subpatent infections from samples collected from three regions of northwest Ethiopia.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>Sub-samples of dried blood spots from the Ethiopian Malaria Indicator Survey 2015 (EMIS-2015) were tested and compared using microscopy, rapid diagnostic tests (RDTs), and nested polymerase chain reaction (nPCR) to determine the prevalence of subpatent infection. Paired seroprevalence results previously reported along with gender, age, and elevation of residence were explored as risk factors for <jats:italic>Plasmodium<\/jats:italic> infection.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Of the 2608 samples collected, the highest positive rate for <jats:italic>Plasmodium<\/jats:italic> infection was found with nPCR 3.3% (95% CI 2.7\u20134.1) compared with RDT 2.8% (95% CI 2.2\u20133.5) and microscopy 1.2% (95% CI 0.8\u20131.7). Of the nPCR positive cases, <jats:italic>Plasmodium falciparum<\/jats:italic> accounted for 3.1% (95% CI 2.5\u20133.8), <jats:italic>Plasmodium vivax<\/jats:italic> 0.4% (95% CI 0.2\u20130.7), mixed <jats:italic>P. falciparum<\/jats:italic> and <jats:italic>P. vivax<\/jats:italic> 0.1% (95% CI 0.0\u20130.4), and mixed <jats:italic>P. falciparum<\/jats:italic> and <jats:italic>Plasmodium malariae<\/jats:italic> 0.1% (95% CI 0.0\u20130.3). nPCR detected an additional 30 samples that had not been detected by conventional methods. The majority of the nPCR positive cases (61% (53\/87)) were from the Benishangul-Gumuz Region. Malaria seropositivity had significant association with nPCR positivity [adjusted OR 10.0 (95% CI 3.2\u201329.4), P\u2009&lt;\u20090.001].<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Using nPCR the detection rate of malaria parasites increased by nearly threefold over rates based on microscopy in samples collected during a national cross-sectional survey in 2015 in Ethiopia. Such subpatent infections might contribute to malaria transmission. In addition to strengthening routine surveillance systems, malaria programmes may need to consider low-density, subpatent infections in order to accelerate malaria elimination efforts.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12936-020-03177-w","type":"journal-article","created":{"date-parts":[[2020,3,4]],"date-time":"2020-03-04T15:02:39Z","timestamp":1583334159000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Assessment of subpatent Plasmodium infection in northwestern Ethiopia"],"prefix":"10.1186","volume":"19","author":[{"given":"Ashenafi","family":"Assefa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Ali","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wakgari","family":"Deressa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Glenn","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amha","family":"Kebede","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hussein","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maruon","family":"Sassine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mebrahtom","family":"Haile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dereje","family":"Dilu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiwot","family":"Teka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew W.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheila","family":"Sergent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Rogier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhou","family":"Zhiyong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian S.","family":"Wakeman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Drakeley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya Ping","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenz","family":"Von Seidlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jimee","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,4]]},"reference":[{"key":"3177_CR1","unstructured":"WHO. World malaria report 2018. Geneva: World Health Organization; 2018. http:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2018\/report\/en\/. Accessed 18 Jan 2019."},{"key":"3177_CR2","volume-title":"National Malaria strategic plan: 2017\u20132020","author":"Federal Ministry of Health Ethiopia (FMOH)","year":"2017","unstructured":"Federal Ministry of Health Ethiopia (FMOH). National Malaria strategic plan: 2017\u20132020. Addis Ababa: Federal Ministry of Health Ethiopia (FMOH); 2017."},{"key":"3177_CR3","unstructured":"WHO. Global Technical Strategy for Malaria 2016\u20132030. Geneva: World Health Organization; 2019. http:\/\/www.who.int\/malaria\/areas\/global_technical_strategy\/en\/. Accessed 26 Mar 2019."},{"key":"3177_CR4","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1016\/S0140-6736(10)61269-X","volume":"376","author":"B Moonen","year":"2010","unstructured":"Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, Smith DL, et al. Operational strategies to achieve and maintain malaria elimination. Lancet. 2010;376:1592\u2013603.","journal-title":"Lancet"},{"key":"3177_CR5","volume-title":"National malaria elimination roadmap","author":"Federal Ministry of Health Ethiopia (FMOH)","year":"2016","unstructured":"Federal Ministry of Health Ethiopia (FMOH). National malaria elimination roadmap. Addis Ababa: National malaria prevention, control and elimination programme; Disease Prevention and Control Directorate; 2016."},{"key":"3177_CR6","unstructured":"United Nations Sustainable Development.\u00a0From aspiration to action: what will it take to end malaria? Report by UN and Gates Foundation presents vision for eradicating malaria by 2040; 2015. https:\/\/www.un.org\/sustainabledevelopment\/blog\/2015\/09\/report-by-un-and-gates-foundation-presents-vision-for-eradicating-malaria-by-2040\/ Accessed 16 May 2019."},{"key":"3177_CR7","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12936-017-1789-9","volume":"16","author":"MT Zaw","year":"2017","unstructured":"Zaw MT, Thant M, Hlaing TM, Aung NZ, Thu M, Phumchuea K, et al. Asymptomatic and sub-microscopic malaria infection in Kayah State, eastern Myanmar. Malar J. 2017;16:138.","journal-title":"Malar J."},{"key":"3177_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/1475-2875-9-254","volume":"9","author":"I Harris","year":"2010","unstructured":"Harris I, Sharrock WW, Bain LM, Gray K-A, Bobogare A, Boaz L, et al. A large proportion of asymptomatic Plasmodium infections with low and sub-microscopic parasite densities in the low transmission setting of Temotu. Malar J. 2010;9:254.","journal-title":"Malar J."},{"key":"3177_CR9","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12936-016-1298-2","volume":"15","author":"G Zhou","year":"2016","unstructured":"Zhou G, Yewhalaw D, Lo E, Zhong D, Wang X, Degefa T, et al. Analysis of asymptomatic and clinical malaria in urban and suburban settings of southwestern Ethiopia in the context of sustaining malaria control. Malar J. 2016;15:250.","journal-title":"Malar J."},{"key":"3177_CR10","doi-asserted-by":"publisher","first-page":"e107693","DOI":"10.1371\/journal.pone.0107693","volume":"9","author":"JM Tsoka-Gwegweni","year":"2014","unstructured":"Tsoka-Gwegweni JM, Okafor U. Asymptomatic malaria in refugees living in a non-endemic South African city. PLoS ONE. 2014;9:e107693.","journal-title":"PLoS ONE"},{"key":"3177_CR11","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12936-016-1336-0","volume":"15","author":"K Phommasone","year":"2019","unstructured":"Phommasone K, Adhikari B, Henriques G, Pongvongsa T, Phongmany P, von Seidlein L, et al. Asymptomatic Plasmodium infections in 18 villages of southern Savannakhet Province, Lao PDR (Laos). Malar J. 2019;15:296.","journal-title":"Malar J."},{"key":"3177_CR12","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12936-016-1124-x","volume":"15","author":"JM Vasquez Jimenez","year":"2016","unstructured":"Vasquez Jimenez JM, Arevalo Herrera M, Henao Giraldo J, Molina Gomez K, Arce Plata M, et al. Consistent prevalence of asymptomatic infections in malaria endemic populations in Colombia over time. Malar J. 2016;15:70.","journal-title":"Malar J."},{"key":"3177_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1186\/s12936-015-1051-2","volume":"14","author":"MA Elbadry","year":"2015","unstructured":"Elbadry MA, Al-Khedery B, Tagliamonte MS, Yowell CA, Raccurt CP, Existe A, et al. High prevalence of asymptomatic malaria infections: a cross-sectional study in rural areas in six departments in Haiti. Malar J. 2015;14:510.","journal-title":"Malar J."},{"key":"3177_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/1475-2875-12-352","volume":"12","author":"L Golassa","year":"2013","unstructured":"Golassa L, Enweji N, Erko B, Aseffa A, Swedberg G. Detection of a substantial number of sub-microscopic Plasmodium falciparum infections by polymerase chain reaction: a potential threat to malaria control and diagnosis in Ethiopia. Malar J. 2013;12:352.","journal-title":"Malar J"},{"key":"3177_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1186\/s12936-015-0821-1","volume":"14","author":"FG Tadesse","year":"2015","unstructured":"Tadesse FG, Pett H, Baidjoe A, Lanke K, Sutherland C, Hall T, et al. Submicroscopic carriage of Plasmodium falciparum and Plasmodium vivax in a low endemic area in Ethiopia where no parasitaemia was detected by microscopy or rapid diagnostic test. Malar J. 2015;14:303.","journal-title":"Malar J."},{"key":"3177_CR16","unstructured":"Wirth D, Alonso P. Malaria: Biology in the Era of Eradication. Latest advances in malaria research in free eBook by Cold Spring Harbor Laboratory Press. Cold Spring Harbor Laboratory; 2017 https:\/\/www.cshl.edu\/latest-advances-malaria-research-free-ebook-cold-spring-harbor-laboratory-press\/. Accessed 30 Jan 2019."},{"key":"3177_CR17","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1093\/cid\/cix1123","volume":"66","author":"FG Tadesse","year":"2018","unstructured":"Tadesse FG, Slater HC, Chali W, Teelen K, Lanke K, Belachew M, et al. The relative Contribution of symptomatic and asymptomatic Plasmodium vivax and Plasmodium falciparum infections to the infectious reservoir in a low-endemic setting in Ethiopia. Clin Infect Dis. 2018;66:1883\u201391.","journal-title":"Clin Infect Dis"},{"key":"3177_CR18","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12936-018-2626-5","volume":"17","author":"P McCreesh","year":"2018","unstructured":"McCreesh P, Mumbengegwi D, Roberts K, Tambo M, Smith J, Whittemore B, et al. Subpatent malaria in a low transmission African setting: a cross-sectional study using rapid diagnostic testing (RDT) and loop-mediated isothermal amplification (LAMP) from Zambezi region, Namibia. Malar J. 2018;17:480.","journal-title":"Malar J."},{"key":"3177_CR19","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41467-019-09441-1","volume":"10","author":"HC Slater","year":"2019","unstructured":"Slater HC, Ross A, Felger I, Hofmann NE, Robinson L, Cook J, et al. The temporal dynamics and infectiousness of subpatent Plasmodium falciparum infections in relation to parasite density. Nat Commun. 2019;10:1433.","journal-title":"Nat Commun."},{"key":"3177_CR20","unstructured":"Ethiopian National Malaria indicator Survey 2015. Ethiopian Public Health Institute; 2016. https:\/\/www.ephi.gov.et\/images\/pictures\/download2009\/MIS-2015-Final-Report-December-_2016.pdf. Accessed 17 Apr 2018."},{"key":"3177_CR21","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12936-019-2874-z","volume":"18","author":"A Assefa","year":"2019","unstructured":"Assefa A, Ali Ahmed A, Deressa W, Sime H, Mohammed H, Kebede A, et al. Multiplex serology demonstrate cumulative prevalence and spatial distribution of malaria in Ethiopia. Malar J. 2019;18:246.","journal-title":"Malar J."},{"key":"3177_CR22","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1186\/1475-2875-13-509","volume":"13","author":"Z Zhou","year":"2014","unstructured":"Zhou Z, Mitchell RM, Gutman J, Wiegand RE, Mwandama DA, Mathanga DP, et al. Pooled PCR testing strategy and prevalence estimation of submicroscopic infections using Bayesian latent class models in pregnant women receiving intermittent preventive treatment at Machinga District Hospital, Malawi, 2010. Malar J. 2014;13:509.","journal-title":"Malar J"},{"key":"3177_CR23","first-page":"39","volume":"10","author":"H Turki","year":"2015","unstructured":"Turki H, Raeisi A, Malekzadeh K, Ghanbarnejad A, Zoghi S, Yeryan M, et al. Efficiency of nested-PCR in detecting asymptomatic cases toward malaria elimination program in an endemic area of Iran. Iran J Parasitol. 2015;10:39\u201345.","journal-title":"Iran J Parasitol."},{"key":"3177_CR24","first-page":"189","volume-title":"Nested PCR analysis of plasmodium parasites. Methods in molecular medicine","author":"S Snounou","year":"2002","unstructured":"Snounou S, Balbir S. Nested PCR analysis of Plasmodium parasites. In: Doolan DL, editor. Nested PCR analysis of plasmodium parasites. Methods in molecular medicine, vol. 72. Totowa: Humana Press Inc; 2002. p. 189\u2013203."},{"key":"3177_CR25","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0166-6851(93)90050-8","volume":"58","author":"G Snounou","year":"1993","unstructured":"Snounou G, Viriyakosol S, Jarra W, Thaithong S, Brown KN. Identification of the four human malaria parasite species in field samples by the polymerase chain reaction and detection of a high prevalence of mixed infections. Mol Biochem Parasitol. 1993;58:283\u201392.","journal-title":"Mol Biochem Parasitol"},{"key":"3177_CR26","volume-title":"Guideline for the treatment of malaria","author":"WHO","year":"2015","unstructured":"WHO. Guideline for the treatment of malaria. Geneva: World Health Organization; 2015."},{"key":"3177_CR27","doi-asserted-by":"publisher","first-page":"012090","DOI":"10.1088\/1755-1315\/125\/1\/012090","volume":"125","author":"L Siahaan","year":"2018","unstructured":"Siahaan L. Laboratory diagnostics of malaria. IOP Conf Ser Earth Environ Sci. 2018;125:012090.","journal-title":"IOP Conf Ser Earth Environ Sci."},{"key":"3177_CR28","volume-title":"Basic malaria microscopy Part I Learner\u2019s guide","author":"WHO","year":"1991","unstructured":"WHO. Basic malaria microscopy Part I Learner\u2019s guide. Geneva: World Health Organization; 1991."},{"key":"3177_CR29","volume-title":"Malaria diagnosis and treatment guidelines for health workers in Ethiopia","author":"Federal Ministry of Health Ethiopia (FMOH)","year":"2004","unstructured":"Federal Ministry of Health Ethiopia (FMOH). Malaria diagnosis and treatment guidelines for health workers in Ethiopia. Addis Ababa: Federal Ministry of Health Ethiopia; 2004."},{"key":"3177_CR30","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/S1473-3099(18)30420-1","volume":"18","author":"AK Verma","year":"2018","unstructured":"Verma AK, Bharti PK, Das A. HRP-2 deletion: a hole in the ship of malaria elimination. Lancet Infect Dis. 2018;18:826\u20137.","journal-title":"Lancet Infect Dis."},{"issue":"9","key":"3177_CR31","doi-asserted-by":"publisher","first-page":"e0203524","DOI":"10.1371\/journal.pone.0203524","volume":"13","author":"Dennis Adu-Gyasi","year":"2018","unstructured":"Adu-Gyasi D, Asante KP, Amoako S, Amoako N, Ankrah L, Dosoo D, et al. Assessing the performance of only HRP2 and HRP2 with pLDH based rapid diagnostic tests for the diagnosis of malaria in middle Ghana, Africa. PLoS ONE. 2018; 13: e0203524. https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6128572\/. Accessed 18 Apr 2019.","journal-title":"PLOS ONE"},{"key":"3177_CR32","doi-asserted-by":"publisher","first-page":"14718","DOI":"10.1038\/s41598-017-15031-2","volume":"7","author":"KB Beshir","year":"2017","unstructured":"Beshir KB, Sep\u00falveda N, Bharmal J, Robinson A, Mwanguzi J, Busula AO, et al. Plasmodium falciparum parasites with histidine-rich protein 2 (pfhrp2) and pfhrp3 gene deletions in two endemic regions of Kenya. Sci Rep. 2017;7:14718.","journal-title":"Sci Rep."},{"key":"3177_CR33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3201\/eid2403.171723","volume":"24","author":"A Berhane","year":"2018","unstructured":"Berhane A, Anderson K, Mihreteab S, Gresty K, Rogier E, Mohamed S, et al. Major threat to malaria control programs by Plasmodium falciparum lacking histidine-rich protein 2, Eritrea. Emerging Infect Dis. 2018;24:462\u201370.","journal-title":"Emerging Infect Dis."},{"key":"3177_CR34","unstructured":"Getie S, Meda AL, Birhanie M, Abere A, Noedl H. High prevalence of Plasmodium falciparum histidine rich protein 2 and 3 gene deletions and their implications for malaria diagnosis in Ethiopia. 66th ASTMH; 2017. p. 97."},{"key":"3177_CR35","doi-asserted-by":"publisher","first-page":"e1001788","DOI":"10.1371\/journal.pmed.1001788","volume":"12","author":"N Hofmann","year":"2015","unstructured":"Hofmann N, Mwingira F, Shekalaghe S, Robinson LJ, Mueller I, Felger I. Ultra-sensitive detection of Plasmodium falciparum by amplification of multi-copy subtelomeric targets. PLoS Med. 2015;12:e1001788.","journal-title":"PLoS Med."},{"key":"3177_CR36","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1038\/ncomms2241","volume":"3","author":"LC Okell","year":"2012","unstructured":"Okell LC, Bousema T, Griffin JT, Ou\u00e9draogo AL, Ghani AC, Drakeley CJ. Factors determining the occurrence of submicroscopic malaria infections and their relevance for control. Nat Commun. 2012;3:1237.","journal-title":"Nat Commun."},{"key":"3177_CR37","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1475-2875-11-126","volume":"11","author":"S Zoghi","year":"2012","unstructured":"Zoghi S, Mehrizi AA, Raeisi A, Haghdoost AA, Turki H, Safari R, et al. Survey for asymptomatic malaria cases in low transmission settings of Iran under elimination programme. Malar J. 2012;11:126.","journal-title":"Malar J."},{"key":"3177_CR38","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4269\/ajtmh.2009.09-0042","volume":"81","author":"SD Fernando","year":"2009","unstructured":"Fernando SD, Abeyasinghe RR, Galappaththy GNL, Rajapaksa LC. Absence of asymptomatic malaria infections in previously high endemic areas of Sri Lanka. Am J Trop Med Hyg. 2009;81:763\u20137.","journal-title":"Am J Trop Med Hyg"},{"key":"3177_CR39","first-page":"13","volume":"17","author":"AF Vallejo","year":"2016","unstructured":"Vallejo AF, Garc\u00eda J, Amado-Garavito AB, Ar\u00e9valo-Herrera M, Herrera S. Plasmodium vivax gametocyte infectivity in sub-microscopic infections. Malar J. 2016;17:13.","journal-title":"Malar J."},{"key":"3177_CR40","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13063-015-0597-1","volume":"16","author":"J Okebe","year":"2015","unstructured":"Okebe J, Bousema T, Affara M, DiTanna G, Eziefula AC, Jawara M, et al. The gametocytocidal efficacy of primaquine in malaria asymptomatic carriers treated with dihydroartemisinin-piperaquine in The Gambia (PRINOGAM): study protocol for a randomised controlled trial. Trials. 2015;16:70.","journal-title":"Trials."},{"key":"3177_CR41","doi-asserted-by":"publisher","first-page":"e0003758","DOI":"10.1371\/journal.pntd.0003758","volume":"9","author":"A Waltmann","year":"2015","unstructured":"Waltmann A, Darcy AW, Harris I, Koepfli C, Lodo J, Vahi V, et al. High rates of asymptomatic, sub-microscopic Plasmodium vivax infection and disappearing Plasmodium falciparum malaria in an area of low transmission. PLoS Negl Trop Dis. 2015;9:e0003758.","journal-title":"PLoS Negl Trop Dis."},{"key":"3177_CR42","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12936-015-0573-y","volume":"14","author":"J Cook","year":"2015","unstructured":"Cook J, Aydin-Schmidt B, Gonz\u00e1lez IJ, Bell D, Edlund E, Nassor MH, et al. Loop-mediated isothermal amplification (LAMP) for point-of-care detection of asymptomatic low-density malaria parasite carriers in Zanzibar. Malar J. 2015;14:43.","journal-title":"Malar J."},{"key":"3177_CR43","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/1475-2875-11-288","volume":"11","author":"K Congpuong","year":"2012","unstructured":"Congpuong K, Saejeng A, Sug-Aram R, Aruncharus S, Darakapong A, Meshnick SR, et al. Mass blood survey for malaria: pooling and real-time PCR combined with expert microscopy in north-west Thailand. Malar J. 2012;11:288.","journal-title":"Malar J."},{"key":"3177_CR44","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s12936-015-1058-8","volume":"15","author":"MD Spring","year":"2016","unstructured":"Spring MD, Pichyangkul S, Lon C, Gosi P, Yongvanichit K, Srichairatanakul U, et al. Antibody profiles to Plasmodium merozoite surface protein-1 in Cambodian adults during an active surveillance cohort with nested treatment study. Malar J. 2016;15:17.","journal-title":"Malar J."},{"key":"3177_CR45","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12936-015-0541-6","volume":"14","author":"SH Hodgson","year":"2015","unstructured":"Hodgson SH, Douglas AD, Edwards NJ, Kimani D, Elias SC, Chang M, et al. Increased sample volume and use of quantitative reverse-transcription PCR can improve prediction of liver-to-blood inoculum size in controlled human malaria infection studies. Malar J. 2015;14:33.","journal-title":"Malar J"},{"key":"3177_CR46","doi-asserted-by":"publisher","first-page":"3303","DOI":"10.1128\/JCM.01057-14","volume":"52","author":"M Imwong","year":"2014","unstructured":"Imwong M, Hanchana S, Malleret B, R\u00e9nia L, Day NPJ, Dondorp A, et al. High-throughput ultrasensitive molecular techniques for quantifying low-density malaria parasitemias. J Clin Microbiol. 2014;52:3303\u20139.","journal-title":"J Clin Microbiol"}],"container-title":["Malaria Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03177-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12936-020-03177-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12936-020-03177-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:31:07Z","timestamp":1614817867000},"score":1,"resource":{"primary":{"URL":"https:\/\/malariajournal.biomedcentral.com\/articles\/10.1186\/s12936-020-03177-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,4]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3177"],"URL":"https:\/\/doi.org\/10.1186\/s12936-020-03177-w","relation":{},"ISSN":["1475-2875"],"issn-type":[{"value":"1475-2875","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,4]]},"assertion":[{"value":"20 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical clearance was obtained from the Health Science College of Addis Ababa, University (AAUMF 03-008). The EMIS-2015 protocol received ethical clearance from the National Research Ethics Review Committee of Ethiopia. The current survey protocol which included molecular testing underwent human subjects review at CDC and was considered a non-research program evaluation activity.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"108"}}